Differential Expression of MicroRNAs in Fibrotic Liver Tissues of Patients with Chronic Hepatitis B

Background: MicroRNAs (miRNAs), which are single-stranded small RNAs approximately 21 to 23 bases long, are involved in the regulation of cell proliferation, apoptosis, and lipid metabolism/fatty acid metabolism, and play important roles in the differentiation of the liver and the maintenance of its morphology and function MiRNAs are also closely related to the occurrence, development, treatment, and prognosis of liver diseases. Fibrotic Liver is a chronic process of the intrahepatic damage–repair response. The mixed effects of these pathogenic factors result in an abnormal comprehensive proliferation of fibrous tissue in the liver, diffused production and deposition of the extracellular matrix (ECM), and an imbalance in ECM synthesis and degradation. These lead to secondary inflammatory responses in the liver and the reversible pathological process of self-healing.Methods: Liver tissues were obtained from 3 patients with CHB with liver histopathological fibrosis grade ≥ S2, 2 patients with CHB with fibrosis grade < S2, and 1 healthy individual with a normal liver. The high-throughput miRNA microarray technique was used for miRNA expression analysis. The screening criteria for differential miRNA expression were a fold-change ≥ 2 and P< 0.005. The miRNAs with significantly different expression levels were verified by quantitative real-time PCR (qPCR), and the target gene functions were predicted by Gene Ontology (GO) and pathway analyses. Finally, an miRNA-gene network map was constructed.Results: In the CHB groups of tissues, 34 miRNAs with ≥ 2-fold difference in expression were found, of which 18 were upregulated and 16 were downregulated. qPCR was used to verify these miRNAs that showed significant differences, with the results showing consistency with the microarray results, indicating that the miRNA microarray results were credible. Bioinformatics analysis results demonstrate that some of the key upregulated miRNAs found in the network map were hsa-miR-125b-2-3p, hsa-miR-4639-3p, hsa-miR-4764-3p, and hsa-miR-3133, whereas some of the key downregulated ones were hsa-miR-1297, hsa-miR-154-5p, hsa-miR-3183 and hsa-miR-663a.Conclusion: In patients with CHB, the miRNA expression profile changes significantly with the severity of fibrotic liver. The development of fibrotic liver may be related to the miRNA-mediated regulation of cell development, metabolism, and apoptosis, and the positive/negative regulation of cell processes.This study was approved by the ethics committee of general hospital of Ningxia medical university (2015-134).

[1]  Xiaoyan Chen Expression of microRNA-3133 correlates with the prognosis in patients with clear cell renal cell carcinoma , 2019, Medicine.

[2]  D. Ippolito,et al.  Utility of Serum miR-122, Liver Enzymes, and Hepatic Histopathology in Response to Hepatotoxicants in Sprague-Dawley Rats , 2018, Toxicologic pathology.

[3]  R. Schwabe,et al.  MicroRNA‐21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis , 2018, Hepatology.

[4]  M. Kumar,et al.  Global microRNA expression profiling in the liver biopsies of hepatitis B virus–infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injury , 2018, Hepatology.

[5]  T. Carvalho,et al.  miRNA-21 ablation protects against liver injury and necroptosis in cholestasis , 2018, Cell Death & Differentiation.

[6]  Yanlei Hao,et al.  Serum microRNA test in one Chinese early-onset familial Alzheimer’s disease and preliminary analysis , 2017 .

[7]  Zu-hua Gao,et al.  Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis , 2017, PloS one.

[8]  Jian Liang,et al.  Modulation of hepatic stellate cells and reversibility of hepatic fibrosis , 2017, Experimental cell research.

[9]  L. Nonn,et al.  microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  J. Iredale,et al.  Regression of Liver Fibrosis , 2017, Seminars in Liver Disease.

[11]  L. Beljaars,et al.  RESEARCH Liver and Biliary Tract Physiology/Pathophysiology WNT-5A regulates TGF- (cid:2) -related activities in liver fibrosis , 2017 .

[12]  C. Girish,et al.  Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury , 2016, European Journal of Clinical Pharmacology.

[13]  Jeongeun Hyun,et al.  MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling. , 2016, World journal of gastroenterology.

[14]  P. Zhang,et al.  miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2. , 2016, Oncology letters.

[15]  F. Wang,et al.  miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1 , 2016, OncoTargets and therapy.

[16]  M. Odenthal,et al.  microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis , 2012, Front. Physio..

[17]  N. Davidson,et al.  MicroRNAs and liver disease. , 2011, Translational research : the journal of laboratory and clinical medicine.

[18]  Kotb Abdelmohsen,et al.  miR-519 suppresses tumor growth by reducing HuR levels , 2010, Cell cycle.